Loading your page…
Loading your page…
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 86
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CAPSFEN | Ibuprofen | Brazil | Authorised | 2014 |
| CETIRIZINE HYDROCHLORIDE ALLERGY10mg | 5mg · Capsule | Cetirizine | United States | Marketed | 2009 |
| CETIRIZINE HYDROCHLORIDE CAPSULES10 mg · Capsule | Cetirizine | Canada | Authorised | |
| IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES25 mg + 200 mg · Capsule | Diphenhydramine, Ibuprofen | Canada | Authorised | |
| IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE CAPSULES200 mg + 30 mg · Capsule | Ibuprofen, Pseudoephedrine | Canada | Authorised | |
| IBUPROFEN CAPSULES, 200 MG200 mg · Capsule | Ibuprofen | Canada | Authorised | |
| IBUPROFEN CAPSULES, 400 MG400 mg · Capsule | Ibuprofen | Canada | Authorised | |
| Ibuprofen Catalent 200 mg zachte capsulesCapsule, zacht | Ibuprofen | Netherlands | Authorised | 2022 |
| Ibuprofen Catalent 400 mg zachte capsulesCapsule, zacht | Ibuprofen | Netherlands | Authorised | 2022 |
| LORATADINE SOFT GELATIN CAPSULES10 mg · Capsule | Loratadine | Canada | Authorised | |
| NAPROXEN CAPSULES 200 MG200 mg · Capsule | Naproxen | Canada | Not marketed | 2015 |
| Abrilada | Adalimumab | Saudi Arabia | Authorised | |
| ACARIZAX 12SQ-HDM ORALLY LYOPHILISATE | Dermatophagoides farinae extract, Dermatophagoides pteronyssinus extract | Saudi Arabia | Authorised | |
| Adtralza | Tralokinumab | Saudi Arabia | Authorised | |
| ANDRIOL TESTOCAPS 40MG | Testosterone | Saudi Arabia | Authorised | |
| AVODART 0.5MG CAPSULE | Dutasteride | Saudi Arabia | Authorised | |
| BRAFTOVI | Encorafenib | Saudi Arabia | Authorised | |
| Brukinsa | Zanubrutinib | Saudi Arabia | Authorised | |
| Copiktra | Duvelisib | Saudi Arabia | Authorised | |
| CURACNE 10MG SOFT GELATIN CAPSULE | Isotretinoin | Saudi Arabia | Authorised | |
| CURACNE 20MG SOFT GELATIN CAPSULE | Isotretinoin | Saudi Arabia | Authorised | |
| CURACNE 40MG SOFT GELATIN CAPSULE | Isotretinoin | Saudi Arabia | Authorised | |
| DUODART Capsule | Dutasteride, Tamsulosin | Saudi Arabia | Authorised | |
| DUODART Capsule | Dutasteride, Tamsulosin | Saudi Arabia | Authorised | |
| ESBRIET 267 mg HARD CAPSULES | Pirfenidone | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 44 | 44 | 0 | CompaniesAll medicines |
| Canada | 26 | 7 | 19 | CompaniesAll medicines |
| Brazil | 13 | 1 | 12 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Croatia, Italy, Serbia, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licence: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA factual register
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Well-known pharmaceutical groups, each with all its companies.